These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 24899496

  • 21. Use of ablation and ultrasonic aspiration at primary debulking surgery in advanced stage ovarian, fallopian tube, and primary peritoneal cancer.
    Li S, Manning-Geist B, Gockley A, Ramos A, Sisodia RC, Del Carmen M, Growdon WB, Horowitz N, Berkowitz R, Worley M.
    Int J Gynecol Cancer; 2020 Jul; 30(7):1052-1057. PubMed ID: 32487686
    [Abstract] [Full Text] [Related]

  • 22. [The 2016 update of the S3 guideline for malignant tumours of the ovary : Role of pathology in diagnosis, therapy and clinical management of epithelial tumours].
    Staebler A, Mayr D.
    Pathologe; 2017 Jul; 38(4):331-344. PubMed ID: 28664411
    [Abstract] [Full Text] [Related]

  • 23. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
    Prat J, FIGO Committee on Gynecologic Oncology.
    Eur J Obstet Gynecol Reprod Biol; 2015 May; 188():133-5. PubMed ID: 25819291
    [No Abstract] [Full Text] [Related]

  • 24. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
    Morency E, Leitao MM, Soslow RA.
    Int J Gynecol Pathol; 2016 May; 35(3):222-9. PubMed ID: 26630225
    [Abstract] [Full Text] [Related]

  • 25. Primary tumor types and origins in positive abdominopelvic washing cytology, a single institution experience.
    Hou Y, Bruehl FK, McHugh KE, Reynolds JP.
    J Am Soc Cytopathol; 2020 May; 9(2):89-94. PubMed ID: 31734259
    [Abstract] [Full Text] [Related]

  • 26. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.
    Mutch DG, Prat J.
    Gynecol Oncol; 2014 Jun; 133(3):401-4. PubMed ID: 24878391
    [No Abstract] [Full Text] [Related]

  • 27. Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists.
    Saida T, Tanaka YO, Matsumoto K, Satoh T, Yoshikawa H, Minami M.
    Jpn J Radiol; 2016 Feb; 34(2):117-24. PubMed ID: 26696400
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
    Wolsky RJ, Price MA, Zaloudek CJ, Rabban JT.
    Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
    [Abstract] [Full Text] [Related]

  • 32. Metastatic patterns do not provide additional prognostic information for patients with FIGO stage IV high-grade serous ovarian cancer.
    Feng Z, Wen H, Ju X, Bi R, Chen X, Yang W, Wu X.
    J Surg Oncol; 2020 Aug; 122(2):315-319. PubMed ID: 32500598
    [Abstract] [Full Text] [Related]

  • 33. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004.
    Goodman MT, Shvetsov YB.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):132-9. PubMed ID: 19124490
    [Abstract] [Full Text] [Related]

  • 34. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.
    Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lecuru F, Lefrere-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Senechal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, Daraï E.
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():214-223. PubMed ID: 30905627
    [Abstract] [Full Text] [Related]

  • 35. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
    Recine MA, Deavers MT, Middleton LP, Silva EG, Malpica A.
    Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686
    [Abstract] [Full Text] [Related]

  • 36. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN, Zeng LX, Li YH, Liu YZ, Wu JY, Li L, Wang Q.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct 25; 52(10):687-696. PubMed ID: 29060967
    [Abstract] [Full Text] [Related]

  • 37. Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years.
    Weiss AS, Swisher E, Pennington KP, Radke M, Khasnavis N, Garcia RL, Kilgore MR, Lee MK, Norquist BM.
    Gynecol Oncol; 2020 Oct 25; 159(1):214-220. PubMed ID: 32709535
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake?
    Höhn AK, Klagges S, Gläser A, Taubenheim S, Dornhöfer N, Einenkel J, Hiller GGR, Brambs CE, Horn LC.
    J Cancer Res Clin Oncol; 2021 Mar 25; 147(3):911-925. PubMed ID: 32915262
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.